Clinical Trial Update: Expanded Access for Bulevirtide

View source ↗

Summary

Gilead Sciences is offering expanded access to bulevirtide for patients with chronic hepatitis D virus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Hepcludex (bulevirtide)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis Delta Virus Infection | Status: AVAILABLE